Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2017 | Challenges with comorbidities and dementia

Dorota Religa • 24 Jun 2017
EAN 2017
Dementia

Dorota Religa, MD, PhD from the Karolinska Institute, Solna, Sweden discusses comorbidities and dementia at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands. Dr Religa explains that comorbidities such as hypertension and heart failure are common but there are no clear guidelines on how to treat them.

More from Dorota Religa

2:33
Anti-amyloid therapy for Alzheimer's disease: beyond the 18-month mark
Dorota Religa • 22 Mar 2024
0:50
Will long-term anti-amyloid treatment show greater clinical benefit?
Dorota Religa • 22 Mar 2024
1:24
Digital frailty screening in dementia
Dorota Religa • 22 Mar 2024
4:28
Most patients excluded from using current anti-amyloid therapies in Alzheimer’s disease
Dorota Religa • 22 Mar 2024

Related Videos

2:33
Anti-amyloid therapy for Alzheimer's disease: beyond the 18-month mark
Dorota Religa • 22 Mar 2024
0:50
Will long-term anti-amyloid treatment show greater clinical benefit?
Dorota Religa • 22 Mar 2024
1:24
Digital frailty screening in dementia
Dorota Religa • 22 Mar 2024
4:19
Current projects from Alzheimer’s Disease International
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals